Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Z. Dessewffy
Observed names:
Z Dessewffy,
Zoltán Dessewffy
Institution:
Novartis (Hungary)
Observed institution:
Novartis (Hungary)
OpenAlex ID:
A5028388383
Cost‐effectiveness of a risk‐based secondary screening programme of type 2 diabetes
2016
·
Balázs Nagy
, Adriána Zsólyom
, et al.
·
Diabetes/Metabolism Research and Reviews
·
18
PRM85 Internal Validation of the Syreon Diabetes Model
2012
·
G. Merész
, L. Nagyjanosi
, et al.
·
Value in Health
·
2
PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 Diabetes
2011
·
B. Nagy
, L. Nagyjanosi
, et al.
·
Value in Health
·
1
Cost-Effectiveness of Theintroduction of A National Adherence Program for Type 2 Diabetes In Hungary
2014
·
A. Zsólyom
, B. Nagy
, et al.
·
Value in Health
Cost-effectiveness of the introduction of a risk stratified population screening for type 2 diabetes in hungary
2014
·
A. Zsólyom
, B. Nagy
, et al.
·
Value in Health
Php34 Patient Access to Innovative Medicines in Hungary
2010
·
O Botlik
, Z Kalotai
, et al.
·
Value in Health
PDF
Show more works
View as search
Works count:
6
Citation count:
21
H-index:
2
I10-index:
1
Year
Topic
Type
